Your browser doesn't support javascript.
loading
A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer.
Kim, Tae-Yong; Han, Hye Sook; Lee, Keun-Wook; Zang, Dae Young; Rha, Sun Young; Park, Young Iee; Kim, Jin-Soo; Lee, Kyung-Hun; Park, Se Hoon; Song, Eun-Kee; Jung, Soo-A; Lee, NaMi; Kim, Yeul Hong; Cho, Jae Yong; Bang, Yung-Jue.
Afiliación
  • Kim TY; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.
  • Han HS; Chungbuk National University College of Medicine, Cheongju, South Korea.
  • Lee KW; Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, South Korea.
  • Zang DY; Hallym University Sacred Heart Hospital, Anyang-si, South Korea.
  • Rha SY; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
  • Park YI; National Cancer Center, Seoul, South Korea.
  • Kim JS; Seoul National University Boramae Medical Center, Seoul, South Korea.
  • Lee KH; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.
  • Park SH; Sungkyunkwan University Samsung Medical Center, Seoul, South Korea.
  • Song EK; Chonbuk National University Medical School, Jeonju, South Korea.
  • Jung SA; Hanmi Pharmaceutical Co., Ltd., Seoul, South Korea.
  • Lee N; Hanmi Pharmaceutical Co., Ltd., Seoul, South Korea.
  • Kim YH; Korea University Anam Hospital, Seoul, South Korea.
  • Cho JY; Gangnam Severance Hospital, Seoul, South Korea.
  • Bang YJ; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, South Korea. bangyj@snu.ac.kr.
Gastric Cancer ; 22(6): 1206-1214, 2019 11.
Article en En | MEDLINE | ID: mdl-30945121

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2019 Tipo del documento: Article